About Mark Smith
Form D filings for Visum Pharma from 2021 to 2023 list Mark Smith as executive officer.
Mark Smith first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Smith in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Smith works with at each company, as listed on that company's latest Form D.
Visum Pharma, Inc. · Form D, Sep 13, 2023
BP
Bernard Peperstraete
Director
PV
Peter Vanderklish
Director
JC
John Costantino
Director
AC
Alex Cuomo
Executive officer
WG
William Gedale
President and CEO, director